Evidence map›Paper›PMID 29855534›Full record

ArticleScientific reports2018

Simultaneous purification of dihydrotanshinone, tanshinone I, cryptotanshinone, and tanshinone IIA from Salvia miltiorrhiza and their anti-inflammatory activities investigation.

Hongwei Gao, Liting Huang, Fang Ding, Ke Yang, Yulin Feng, Hongzhen Tang, Qiong-Ming Xu, Jianfang Feng, Shilin Yang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Plants (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Article
  9. Protective effects of tanshinone ⅡA on sepsis-induced multiple organ dysfunction: a literature review.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2023
    Review
  10. Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways.Naunyn-Schmiedeberg's archives of pharmacology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Frontiers in pharmacology · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Hongwei GaoGuangxi University of Chinese Medicine, Nanning, 530000, China.ORCID 0000-0001-9179-750X
Liting HuangGuangxi University of Chinese Medicine, Nanning, 530000, China.
Fang DingGuangxi University of Chinese Medicine, Nanning, 530000, China.
Ke YangGuangxi University of Chinese Medicine, Nanning, 530000, China.
Yulin FengState Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330004, China. fengyulin2003@126.com.
Hongzhen TangGuangxi University of Chinese Medicine, Nanning, 530000, China. 383744825@qq.com.
Qiong-Ming XuCollege of Pharmaceutical Science, Soochow University, Suzhou, 215123, China.
Jianfang FengGuangxi University of Chinese Medicine, Nanning, 530000, China.
Shilin YangGuangxi University of Chinese Medicine, Nanning, 530000, China.
Guangxi University of Chinese Medicine · CNJiangxi University of Traditional Chinese Medicine · CNGuangxi University · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dihydrotanshinone, tanshinone I, cryptotanshinone, and tanshinone IIA are major lipid-soluble constituents isolated from Salvia miltiorrhiza Bunge (Danshen). In the present study, a systematic method was developed to simultaneously isolate and purify those compounds using macroporous adsorption resins and semi-preparative HPLC with a dynamic axial compress (DAC) system. The Danshen extract (95% alcohol) was divided into three fractions using different concentrations of alcohol (0%, 45%, and 90%) on D101 column. The content of total tanshinones of 90% alcohol eluent (TTS) was over 97%. Furthermore, the anti-inflammatory effects of those samples were investigated on LPS-stimulated RAW264.7 cells and three animal models. The results showed that the anti-inflammatory effect of TTS in vitro was superior to the one of any other sample including 0% and 45% eluent, and total tanshinones capsules. In addition, TTS exhibited a stronger anti-inflammatory effect than that of dihydrotanshinone, tanshinone IIA, cryptotanshinone, and tanshinone I, respectively. For animal models, TTS could significantly suppress xylene-induced ear oedema and rescue LPS-induced septic death and acute kidney injury in mice. In summary, the separation process developed in the study was high-efficiency, economic, and low-contamination, which was fit to industrial producing. TTS is a potential agent for the treatment of inflammatory diseases.

Indexed as

AbietanesAcute Kidney InjuryAnimalsAnti-Inflammatory AgentsChromatography, High Pressure LiquidCytokinesDisease Models, AnimalKidneyLipopolysaccharidesMacrophagesMiceMice, Inbred BALB CNitric OxidePhenanthrenesRAW 264.7 CellsSalvia miltiorrhizaAbietanesAnti-Inflammatory AgentscryptotanshinoneCytokinesLipopolysaccharidesNitric OxidePhenanthrenestanshinone

Identifiers

PMID29855534
PMCPMC5981213
OpenAlexW2806730922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.